retatrutide clinical trials status 2025 Weight Loss Results:Trial Data and FDA retatrutide clinical trial results 2025

You can take Zepbound with or without food

The dosage is typically adjusted based on individual patient needs and treatment response

Higher concentrations may increase results but also increase irritation risk

Without PBS subsidy for obesity indications, patients pay full price: Wegovy: approximately $320$450 per month Saxenda: approximately $390$440 per month Mounjaro (off-label for weight loss): approximately $280$750 per month depending on dose PBS listing for obesity indications is an ongoing discussion, with health economists and advocacy groups pushing for subsidised access given the long-term healthcare costs associated with untreated obesity